Back to search

Article

ADAM10 gene polymorphism and its relationship to hepatocellular carcinoma in Egyptian HCV patients receiving direct-acting antiviral therapies (DAAs)

2022-06-08

Abstract excerpt

<h4>Background: </h4> Hepatocellular carcinoma (HCC) is a multifactorial disease needs widened genetic studies. Taking in consideration the probable role of new direct-acting antiviral therapies (DAAs) of Hepatitis C infection (HCV) as predisposing factor of HCC as it provides longer lifetime for many late cirrhotic patients to develop hepatocellular carcinoma. Considering the reported potential biological roles o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cc5cc529-bb61-55d6-b962-51ca245da6b8
DOI
10.21203/rs.3.rs-1701191/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ADAM10 gene polymorphism and its relationship to hepatocellular carcinoma in Egyptian HCV patients receiving direct-acting antiviral therapies (DAAs)DOI 10.21203/rs.3.rs-1701191/v1
Select a neighboring publication to make it the new centre.